Dyspepsia
📧 Sign up to get email alerts when something new happens for Dyspepsia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-05-23Clinical Trial Update: Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children [Phase 3]
Phase 3 clinical trial evaluating lidocaine topical spray as an adjuvant to upper gastrointestinal endoscopy in children has completed.
-
CLINICAL_TRIALS research · 2008-05-07Clinical Trial Update: The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal Metaplasia
This entry reports on a clinical trial evaluating narrow-band imaging endoscopy for diagnosing gastric intestinal metaplasia in patients wit…
-
FDA approval · 2008-02-27FDA Approved: FAMOTIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for famotidine from Teva Pharmaceuticals USA, Inc., updating the approved generic product.
-
CLINICAL_TRIALS trial_result · 2008-02-01Clinical Trial Update: The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn. [Phase 3]
A Phase 3 clinical trial evaluated tegaserod therapy for managing dyspeptic symptoms in female patients on proton pump inhibitors for heartb…
-
CLINICAL_TRIALS trial_result · 2008-02-01Clinical Trial Update: Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia [Phase 3]
Extension study to assess the long-term safety of tegaserod in women with symptoms of dyspepsia (Phase 3) sponsored by Novartis; the study s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-02-01Clinical Trial Update: Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia [Phase 3]
Phase 3 trial assessing the efficacy and safety of tegaserod versus placebo in women with dyspepsia has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-01Clinical Trial Update: Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia [Phase 3]
An extension Phase 3 trial evaluating the long-term safety of tegaserod in women with dyspepsia has completed.
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia. [Phase 3]
This Clinical Trial Update reports on a Phase 3 study of tegaserod in patients with heartburn and dyspepsia, assessing mechanical sensitivit…
-
FDA approval · 2007-08-31FDA Approved: RANITIDINE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved the original ANDA for ranitidine from Dr. Reddy's Laboratories Limited, enabling a generic ranitidine product to be marketed in…
-
CLINICAL_TRIALS trial_result · 2007-08-29Clinical Trial Update: Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study) [NA]
A completed clinical trial (the DIAMOND study) comparing Step-Up versus Step-Down treatment strategies for new-onset dyspepsia in general pr…
-
CLINICAL_TRIALS trial_result · 2006-08-15Clinical Trial Update: Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice [Phase 4]
Phase 4 clinical trial update examining long-term use of proton-pump inhibitors in general practice, with conditions including dyspepsia, ga…